RA
RPID icon

Royce & Associates’s Rapid Micro Biosystems RPID Stock Holding History

Royce & Associates’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17,900
Closed -$58K – 954
2022
Q3 		$58K Buy
+17,900
New +$69.5K ﹤0.01% 915

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
KLM
Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $8.55M AUM 12.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Royce & Associates's RPID Position: Q4 2022 in Review

Royce & Associates sold out of Rapid Micro Biosystems (RPID) in Q4 2022, closing a stake of 17,900 shares — an estimated $58K sold.

Royce & Associates first reported a position in RPID in Q3 2022 and held it in 1 quarter. The position peaked at $58K in Q3 2022. 42 funds tracked by Wall St. Rank hold RPID as of Q4 2022.

  • Royce & Associates reported no remaining Rapid Micro Biosystems position as of Q4 2022 after selling out during the quarter.
  • Royce & Associates sold 17,900 Rapid Micro Biosystems shares in Q4 2022, an estimated $58K.
  • Royce & Associates first reported a position in Rapid Micro Biosystems in Q3 2022 and held it in 1 quarter.
  • Royce & Associates's Rapid Micro Biosystems position peaked at $58K in Q3 2022.
  • 42 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q4 2022.

Based on Royce & Associates's 13F filing for Q4 2022, filed 13 Feb 2023.